Published in J Infect Dis on December 01, 1975
Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J Exp Med (1978) 2.33
Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79
The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man. Clin Exp Immunol (1978) 1.40
Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice. J Clin Invest (1977) 1.12
Suppression of antibody-mediated accumulation of eosinophils in chronic inflammatory lesions by concomitant delayed hypersensitivity reactions. Immunology (1980) 0.91
The enhancement of eosinophil function by lymphocyte supernatants. Clin Exp Immunol (1983) 0.90
The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration. Immunology (1980) 0.84
Lymphokine-mediated stimulation of eosinophil migration in the guinea-pig. Immunology (1981) 0.79
Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02
Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med (1970) 4.50
Giardiasis in the mouse: an animal model. Gastroenterology (1976) 4.47
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04
Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development (1996) 3.63
A chromosome bin map of 16,000 expressed sequence tag loci and distribution of genes among the three genomes of polyploid wheat. Genetics (2004) 3.37
Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature (1975) 2.92
Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol (1975) 2.59
Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci U S A (2001) 2.41
Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol (1999) 2.25
The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23
A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19
Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am J Pathol (1968) 2.18
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils. J Exp Med (1977) 2.06
Random distribution of mixed species malaria infections in Papua New Guinea. Am J Trop Med Hyg (2000) 2.04
The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol (1966) 2.03
Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A (1999) 1.91
The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg (1972) 1.91
Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish. Development (1997) 1.84
Dispersion of papers among journals based on a mathematical analysis of two diverse medical literatures. Nature (1969) 1.79
Lassa fever in Britain: an imported case. Br Med J (1973) 1.72
Acquired resistance to infection in an animal model of giardiasis. J Immunol (1976) 1.70
Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68
Tropical medicine. BMJ (2000) 1.67
Stage-specific antibody-dependent eosinophil-mediated destruction of Trichinella spiralis. Nature (1978) 1.65
In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest (1997) 1.64
Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61
The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58
Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol (1993) 1.57
Granuloma formation around Schistosoma mansoni, S. HAEMATOBIUM, AND S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg (1970) 1.56
Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae. J Lab Clin Med (1991) 1.52
Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis (1973) 1.47
The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma. J Exp Med (1970) 1.44
A functional classification of granulomatous inflammation. Ann N Y Acad Sci (1976) 1.44
An application of the Kermack-McKendrick theory to the epidemiology of schistosomiasis. Am J Trop Med Hyg (1970) 1.43
Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg (1980) 1.43
Thymus dependency of host resistance to Giardia muris infection: studies in nude mice. J Immunol (1978) 1.42
Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A. Infect Immun (1976) 1.42
Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest (1976) 1.41
Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol (1977) 1.37
Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea. Med Vet Entomol (2002) 1.35
Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol (1981) 1.35
The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood (2001) 1.34
Hepatosplenic schistosomiasis mansoni: an immunologic disease. Bull N Y Acad Med (1975) 1.34
Analysis of expressed sequence tag loci on wheat chromosome group 4. Genetics (2004) 1.33
The inhibition of granuloma formation around Schistosoma mansoni eggs. I. Immunosuppressive drugs. Am J Trop Med Hyg (1967) 1.33
Th ecology of the medical literatures. Am J Med Sci (1972) 1.32
Application of a polymerase chain reaction-ELISA to detect Wuchereria bancrofti in pools of wild-caught Anopheles punctulatus in a filariasis control area in Papua New Guinea. Am J Trop Med Hyg (2000) 1.32
Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol (1997) 1.31
Dynamics of antigen and mitogen-induced responses in murine schistosomiasis japonica: in vitro comparison between hepatic granulomas and splenic cells. J Immunol (1981) 1.31
Selective primary health care: an interim strategy for disease control in developing countries. Soc Sci Med Med Econ (1980) 1.31
Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet (1998) 1.30
Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci U S A (1997) 1.30
Chromosome bin map of expressed sequence tags in homoeologous group 1 of hexaploid wheat and homoeology with rice and Arabidopsis. Genetics (2004) 1.29
Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol (1974) 1.29
The Schistosoma mansoni egg granuloma: quantitation of cell populations. J Pathol (1977) 1.29
Frequencies of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland malaria-endemic areas of Kenya. Trans R Soc Trop Med Hyg (2004) 1.29
The secretion of migration inhibitory factor by intact schistosome egg granulomas maintained in vitro. Nature (1973) 1.28
Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol (1975) 1.27
T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect Immun (1997) 1.27
Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon. N Engl J Med (1974) 1.27
B cell sensitization to helminthic infection develops in utero in humans. J Immunol (1998) 1.26
Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol (1978) 1.26
Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases. J Infect Dis (1977) 1.25
Drugs five years later: praziquantel. Ann Intern Med (1989) 1.23
Increased incidence of hepatoma in mice with chronic schistosomiasis mansoni treated with a carcinogen. Am J Pathol (1967) 1.23
Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest (1981) 1.22
Calcium extrusion is critical for cardiac morphogenesis and rhythm in embryonic zebrafish hearts. Proc Natl Acad Sci U S A (2005) 1.21
Algorithms in the Diagnosis and Management of Exotic Diseases. ii. Giardiasis. J Infect Dis (1975) 1.21
Schistosoma mansoni soluble egg antigens. I. Identification and purification of three major antigens, and the employment of radioimmunoassay for their further characterization. J Immunol (1976) 1.21
In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages. J Immunol (1979) 1.21
Adoptive transfer of modulation of granuloma formation and hepatosplenic disease in murine schistosomiasis japonica by serum from chronically infected animals. J Immunol (1982) 1.20
Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Immunology (1994) 1.19
Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ (1976) 1.19
Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg (1988) 1.19
Morbidity in Schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am J Trop Med Hyg (1976) 1.19
Rapid, accurate quantification of schistosome eggs via nuclepore filters. J Parasitol (1976) 1.18
Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med (1975) 1.18
Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med (1995) 1.18
Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya. Trans R Soc Trop Med Hyg (1990) 1.17
Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii. Nature (1976) 1.16
IL-12 exacerbates helminth-mediated corneal pathology by augmenting inflammatory cell recruitment and chemokine expression. J Immunol (1997) 1.16